Results 31 to 40 of about 187,919 (323)

Beta-blockers in Cardiovascular Therapy: A Review

Journal of Mind and Medical Sciences, 2019
The role of beta-adrenergic receptor antagonists in cardiovascular therapy has been the subject of various studies over time, these agents representing one of the oldest class of drugs used for the treatment of cardiovascular diseases.
Camelia C. Diaconu, Dragos R. Marcu, Ovidiu G. Bratu, Ana Maria A. Stanescu, Gina Gheorghe, Andreea A. Hlescu, Dan LD. Mischianu, Maria Manea   +7 more
doaj   +1 more source

Clinical and molecular characterization of a cardiac ryanodine receptor founder mutation causing catecholaminergic polymorphic ventricular tachycardia [PDF]

, 2015
Background Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a difficult-to-diagnose cause of sudden cardiac death (SCD). We identified a family of 1400 individuals with multiple cases of CPVT, including 36 SCDs during youth.
Allegue, Catarina, Beltran-Alvarez, Pedro, Berne, Paola, Bosch Calero, Cristina, Brugada, Josep, Brugada, Ramon, Campuzano, Oscar, Iglesias, Anna, Pérez, Carmelo, Pérez, Guillermo J., Ruiz Hernandez, Pablo M., Scornik, Fabiana S., Wangüemert, Fernando   +12 more
core   +2 more sources

Beta adrenergic blockers poisoning [PDF]

ABC: časopis urgentne medicine, 2016
AIM: To demonstrate the basic characteristics in terms of clinical features and a basic method of treatment in β-adrenergic blockers poisoning. MATERIALS AND METHODS: Review of the available literature, the protocols of departments that participated in ...
Tadić Milorad, Stanimirović Marijana
doaj  

The use of non-selective beta-blockers in patients with cirrhosis: more doubts than certainties [PDF]

, 2017
In conclusion, prospective RCT would be needed on the use of NSBBs in decompensated cirrhotic patients with ascites however these trials are difficult to organize and will need a large sample size.
Di Gregorio, Vincenza, D’Ambrosio, Daria, Lattanzi, Barbara, Merli, Manuela   +3 more
core   +1 more source

The place of metoprolol tartrate in the treatment of cardiovascular diseases

Медицинский совет, 2016
Since the beginning of the 1960s, beta-blockers have been number one medications in the treatment of cardiovascular diseases. A number of randomized controlled trials (RCTs) demonstrated positive effect of beta-blockers on morbidity and mortality [1]. It
N. V. Romanova, I. V. Zhirov
doaj   +1 more source

Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. [PDF]

, 2005
BACKGROUND: Nonselective beta-adrenergic blockers decrease portal pressure and prevent variceal hemorrhage. Their effectiveness in preventing varices is unknown.
Bosch, J, Burroughs, AK, Escorsell, A, Gao, H, Garcia-Pagan, JC, Garcia-Tsao, G, Grace, ND, Groszmann, RJ, Makuch, R, Matloff, DS, Patch, D, Planas, R, Portal Hypertension Collaborative Group   +12 more
core   +1 more source

Antihypertensive Drug Use and the Risk of Depression: A Systematic Review and Network Meta-analysis

Frontiers in Pharmacology, 2021
Background: Although numerous cohort studies have reported an association between antihypertensives use and depression, the exact effect of antihypertensives on depression remains unclear.Objective: To clarify the association between antihypertensives ...
Ying Li, Yuanming Fan, Yangyang Sun, Raphael N. Alolga, Pingxi Xiao, Gaoxiang Ma   +5 more
doaj   +1 more source

An Update on the Use of Molecularly Imprinted Polymers in Beta-Blocker Drug Analysis as a Selective Separation Method in Biological and Environmental Analysis

Molecules, 2022
Beta-blockers are antihypertensive drugs and can be abused by athletes in some sport competitions; it is therefore necessary to monitor beta-blocker levels in biological samples.
Aliya Nur Hasanah, Ike Susanti, Mutakin Mutakin   +2 more
doaj   +1 more source

The association between beta-blocker use and chronic obstructive pulmonary disease risk, severity, and exacerbation

Medical Journal of Babylon, 2021
Background: There is controversy about the role of beta-blockers in the number of acute exacerbations in patients with chronic obstructive pulmonary disease (COPD).
Hemin Khalid Saber
doaj   +1 more source

Beta blockers and their combinations in the management of hypertension

South African Family Practice, 2012
Beta blockers have been prescribed for the treatment of primary hypertension for a very long time. Currently, it is doubtful whether this is still a good idea. In fact, many are of the opinion that beta blockers should be relegated to a fourth-line drug,
J.A. Ker
doaj   +1 more source